T.Man Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
T.Man Pharmaceutical has a total shareholder equity of THB526.3M and total debt of THB224.8M, which brings its debt-to-equity ratio to 42.7%. Its total assets and total liabilities are THB2.5B and THB2.0B respectively. T.Man Pharmaceutical's EBIT is THB519.7M making its interest coverage ratio 41.2. It has cash and short-term investments of THB105.5M.
Key information
42.7%
Debt to equity ratio
฿224.84m
Debt
| Interest coverage ratio | 41.2x |
| Cash | ฿105.50m |
| Equity | ฿526.34m |
| Total liabilities | ฿1.95b |
| Total assets | ฿2.48b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TMAN's short term assets (THB1.2B) do not cover its short term liabilities (THB1.9B).
Long Term Liabilities: TMAN's short term assets (THB1.2B) exceed its long term liabilities (THB102.5M).
Debt to Equity History and Analysis
Debt Level: TMAN's net debt to equity ratio (22.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if TMAN's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: TMAN's debt is well covered by operating cash flow (228.6%).
Interest Coverage: TMAN's interest payments on its debt are well covered by EBIT (41.2x coverage).